4th Quarter - Report

TODD STRATEGY GROUP for NOVARTIS, INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Supply Chain. 340B Issues. H.R.5376 - Inflation Reduction Act of 2022. PDUFA. Outcomes based contracting/value-based arrangements. Vaccines.

LobbyistCovered position, as disclosed
PAUL EDATTEL Chief Health Counsel, House Energy & Commerce Committee; Policy Assistant, Office of the Speaker; Professional Staff Member for the Majority at the House Energy & Commerce Committee; Legislative Assistant & Legislative Director, Rep. John Shadegg
JEFF LUCAS Health Policy Advisor, Senator Bill Cassidy; Legislative Assistant/Sr. Legislative Assistant/Legislative Correspondent, Representative Larry Bucshon
DANIEL M TODD Senior Health Counsel, Senate Finance Committee; Special Assistant, Office of Admin. Ct. - Medicare & Medicaid
NICHOLAS UEHLECKE Senior Advisor, Dept. of Health and Human Services; Professional Staff/Sr. Legislative Assistant, House Ways and Means Subcommittee

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Bills named: H.R. 5376 (117th)

Medicare/Medicaid MMM

Center for Medicare and Medicaid Innovation (CMMI) policy issues. Drug Pricing.

LobbyistCovered position, as disclosed
PAUL EDATTEL —
JEFF LUCAS —
DANIEL M TODD —
NICHOLAS UEHLECKE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.